Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.
According to MarketsandMarketstm, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 and USD 30.39 billion by 2032, exhibiting a CAGR of 6.2% ...
UCSF Health formed a collaboration with a large radiology equipment provider to enable expanded radiologic technologist (rad tech) education, magnetic resonance (MR) excellence, and remote imaging ...
Jazz Pharmaceuticals is positioned for long-term value creation, with a relief rally following Q4 2025 results and the 2026 ...
GMRx2 is an innovative single pill combination of three medicines designed to deliver the blood pressure-lowering benefits of triple combination ...
Jazz Pharmaceuticals (NASDAQ:JAZZ) reported fourth-quarter and full-year 2025 results that management characterized as a “transformational” year, highlighted by record revenue, multiple regulatory ...
The firm is anticipating FDA approval for the bispecific antibody in HER2-positive gastroesophageal cancer this year and advancing the treatment in breast cancer studies.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2025 and provided financial guidance for 2026.
Jazz Pharmaceuticals plc ( JAZZ) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results